Clinical trial / 2017
Oral cannabis in brownies produced dose-dependent subjective and performance effects that peaked at 1.5–3 hours, with low cannabinoid concentrations.
Healthy adults were administered cannabis brownies containing 10, 25, or 50 mg THC, with whole blood, oral fluid, and pharmacodynamic outcomes tracked over 9 days. Mean Cmax for THC in whole blood was 1, 3.5, and 3.3 ng/mL for the 10, 25, and 50 mg doses, with detection windows ranging from 0 to 22 h in blood and 1.9 to 22 h in oral fluid. Subjective drug and cognitive performance effects were generally dose dependent, peaked at 1.5–3 h post-administration, and lasted 6–8 h. Whole blood cannabinoid concentrations significantly correlated with subjective effects, but correlations with cognitive performance or between oral fluid and pharmacodynamic outcomes were non-significant or not orderly by dose.
- Study type
- Controlled pharmacokinetic and pharmacodynamic trial
- Who was studied
- Healthy adults (N = 6 per dose)
- What was measured
- Whole blood and oral fluid cannabinoid pharmacokinetics, subjective, cardiovascular, and performance effects
THE PAPER
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.
Vandrey R, Herrmann ES, Mitchell JM, Bigelow GE, Flegel R, LoDico C, Cone EJ. J Anal Toxicol, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.